Quetiapine-associated depression in a patient with schizophrenia

Joseph Mergui, Sol Jaworowski, Vladimir Lerner

    Research output: Contribution to journalArticlepeer-review

    6 Scopus citations


    Depression has been reported as a side effect of a wide variety of drugs in clinical medicine. Neuroleptics may cause depression in persons with or without any past history of psychiatric illness. Clinically, these drug-induced depressions may go unnoticed and thus create therapeutic problems. The authors present a case of quetiapine-associated depression in a patient being treated for schizophrenia. To the best of our knowledge it is the first description of depression associated with quetiapine treatment. This case report suggests that atypical antipsychotics may be a cause of depression. This is noteworthy because these medications have been found in the past to have an antidepressant action. Further data based on controlled studies are needed.

    Original languageEnglish
    Pages (from-to)133-135
    Number of pages3
    JournalClinical Neuropharmacology
    Issue number3
    StatePublished - 1 May 2005


    • Atypical neuroleptics
    • Neuroleptic-associated depression
    • Quetiapine
    • Schizophrenia

    ASJC Scopus subject areas

    • Pharmacology
    • Clinical Neurology
    • Pharmacology (medical)


    Dive into the research topics of 'Quetiapine-associated depression in a patient with schizophrenia'. Together they form a unique fingerprint.

    Cite this